Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study

Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, Jean Luc Canon, Matthew D. Galsky, Erika Hamilton, Hidetoshi Hayashi, Guy Jerusalem, Seung Tae Kim, Keun Wook Lee, Lionel Aurelien Kankeu Fonkoua, Bradley J. Monk, Danny Nguyen, Do Youn Oh, Alicia Okines, David M. O'Malley, Paula Pohlmann, Martin Reck, Sang Joon Shin, Kazuki SudoShunji Takahashi, Cedric Van Marcke, Evan Y. Yu, Roman Groisberg, Jorge Ramos, Sherry Tan, Thomas E. Stinchcombe, Tanios Bekaii-Saab

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study'. Together they form a unique fingerprint.

Medicine & Life Sciences